Pay in 4 interest-free payments of $6.77 Learn more
Ships within 48 hours · Estimated delivery Oct 9 - Oct 14
Standard Dosing Ranges The most extensively studied dosing protocols for subcutaneous administration include: Research-Based Dosing Protocols Beginner/Conservative Protocol: Dose: 250-300 mcg once daily Duration: 4-8 weeks initial assessment period Rationale: Allows tolerance assessment and response evaluation at lower end of therapeutic range Standard Protocol: Dose: 300-500 mcg once daily Duration: 12-24 weeks based on clinical trials Rationale: Most commonly studied range in human research with optimal benefit-to-safety ratio Advanced Protocol: Dose: 500 mcg-1 mg once daily Duration: 12-24 weeks under close medical monitoring Rationale: Upper clinical range
Clear dose indicators, intuitive controls, and ergonomic design are essential for ensuring safe patient use
The current availability of retatrutide is limited to clinical trial participation and research-grade supply through peptide suppliers
Li C, Navarrete J, Liang-Guallpa J, Lu C, Funderburk SC, Chang RB, et al
ng chn ch
